Bionano Genomics (BNGO) Return on Invested Capital (2018 - 2026)

Bionano Genomics has reported Return on Invested Capital for 9 years, with the latest figure at 0.04% in Q1 2026.

• Quarterly Return on Invested Capital rose 2.0% year-over-year to 0.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 2.0% YoY) and the FY2024 annual result came in at 0.27%, up 28.0% from the prior year.
• Return on Invested Capital fell to 0.04% in Q1 2026 per BNGO's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.01% in Q4 2025 and troughed at 0.15% in Q1 2022.
• A 5-year average of 0.09% and a median of 0.09% in 2022 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2022 and 2025: Return on Invested Capital dropped 14 bps in 2022, then grew 8 bps in 2025.
• Over 5 years, Return on Invested Capital stood at 0.09% in 2022, then slumped by 63 bps to 0.14% in 2023, then soared by 51 bps to 0.07% in 2024, then jumped by 83 bps to 0.01% in 2025, then plunged by 208 bps to 0.04% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.04%, 0.01%, and 0.02% for Q1 2026, Q4 2025, and Q3 2025 respectively.